PILOCARPINE HYDROCHLORIDE tablet, film coated

Țară: Statele Unite ale Americii

Limbă: engleză

Sursă: NLM (National Library of Medicine)

Ingredient activ:

PILOCARPINE HYDROCHLORIDE (UNII: 0WW6D218XJ) (PILOCARPINE - UNII:01MI4Q9DI3)

Disponibil de la:

Bryant Ranch Prepack

Calea de administrare:

ORAL

Tip de prescriptie medicala:

PRESCRIPTION DRUG

Indicații terapeutice:

INDICATIONS AND USAGE Pilocarpine hydrochloride tablets are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with Sjogren's Syndrome.

Rezumat produs:

NDC: 71335-2094-1: 30 TABLETs in a BOTTLE

Statutul autorizaţiei:

Abbreviated New Drug Application

Caracteristicilor produsului

PILOCARPINE HYDROCHLORIDE- PILOCARPINE HYDROCHLORIDE TABLET, FILM
COATED
BRYANT RANCH PREPACK
----------
PILOCARPINE HYDROCHLORIDE TABLETS, USP
RX ONLY
DESCRIPTION
Pilocarpine hydrochloride tablets, USP contain pilocarpine
hydrochloride, a cholinergic
agonist for oral use. Pilocarpine hydrochloride is a white or almost
white, crystalline
powder or colorless crystals, hygroscopic which is very soluble in
water and freely
soluble in ethanol (96 percent). Pilocarpine hydrochloride, with a
chemical name of
(3_S_-_cis_)-2(3_H_)-Furanone,
3-ethyldihydro-4-[(1-methyl-1_H_-imidazol-5-yl)methyl]
monohydrochloride, has a molecular weight of 244.72.
Each 5 mg pilocarpine hydrochloride tablet, USP for oral
administration contains 5 mg of
pilocarpine hydrochloride USP. Inactive ingredients in the tablet are:
hypromellose,
microcrystalline cellulose, polyethylene glycol, stearic acid and
titanium dioxide.
Each 7.5 mg pilocarpine hydrochloride tablet, USP for oral
administration contains 7.5
mg of pilocarpine hydrochloride USP. Inactive ingredients in the
tablet are: FD&C blue #
2, hypromellose, microcrystalline cellulose, polyethylene glycol,
stearic acid and titanium
dioxide.
FDA approved dissolution test specifications differ from USP.
CLINICAL PHARMACOLOGY
PHARMACODYNAMICS:
Pilocarpine is a cholinergic parasympathomimetic agent exerting a
broad spectrum of
pharmacologic effects with predominant muscarinic action. Pilocarpine,
in appropriate
dosage, can increase secretion by the exocrine glands. The sweat,
salivary, lacrimal,
gastric, pancreatic, and intestinal glands and the mucous cells of the
respiratory tract
may be stimulated. When applied topically to the eye as a single dose
it causes miosis,
spasm of accommodation, and may cause a transitory rise in intraocular
pressure
followed by a more persistent fall. Dose-related smooth muscle
stimulation of the
intestinal tract may cause increased tone, increased motility, spasm,
and tenesmus.
Bronchial smooth muscle tone may increase. The tone and motility of
urinary tract,
ga